Robert Olstein's ZBH Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 82,000 shares of Zimmer Biomet Holdings, Inc. (ZBH) worth $7.37 M, representing 1.51% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Robert Olstein has maintained a long-term strategic position in ZBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2016, adding 109,000 shares. Largest reduction occurred in Q3 2022, reducing 96,500 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Zimmer Biomet Holdings (ZBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zimmer Biomet Holdings (ZBH) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +93,731 | Add 0.00% | 93,730 | $72.76 |
| Q3 2013 | -15,450 | Reduce 16.48% | 78,280 | $79.75 |
| Q4 2013 | -5,150 | Reduce 6.58% | 73,130 | $90.47 |
| Q1 2014 | -4,120 | Reduce 5.63% | 69,010 | $91.83 |
| Q2 2014 | +20,600 | Add 29.85% | 89,610 | $100.84 |
| Q3 2014 | +21,630 | Add 24.14% | 111,240 | $97.62 |
| Q4 2014 | -26,780 | Reduce 24.07% | 84,460 | $110.11 |
| Q1 2015 | -11,330 | Reduce 13.41% | 73,130 | $114.10 |
| Q2 2015 | +3,090 | Add 4.23% | 76,220 | $106.05 |
| Q3 2015 | +38,110 | Add 50.00% | 114,330 | $91.19 |
| Q4 2015 | +6,180 | Add 5.41% | 120,510 | $99.60 |
| Q1 2016 | -11,330 | Reduce 9.40% | 109,180 | $103.53 |
| Q2 2016 | -30,900 | Reduce 28.30% | 78,280 | $116.88 |
| Q3 2016 | -10,300 | Reduce 13.16% | 67,980 | $126.23 |
| Q4 2016 | +109,000 | Add 160.34% | 176,980 | $100.19 |
| Q1 2017 | -36,236 | Reduce 20.47% | 140,744 | $118.56 |
| Q2 2017 | -26,661 | Reduce 18.94% | 114,083 | $124.66 |
| Q3 2017 | +22,598 | Add 19.81% | 136,681 | $113.68 |
| Q4 2017 | +9,795 | Add 7.17% | 146,476 | $117.15 |
| Q1 2018 | -4,810 | Reduce 3.28% | 141,666 | $105.86 |
| Q2 2018 | +3,966 | Add 2.80% | 145,632 | $108.20 |
| Q3 2018 | -35,937 | Reduce 24.68% | 109,695 | $127.64 |
| Q4 2018 | +361 | Add 0.33% | 110,056 | $100.69 |
| Q1 2019 | -7,056 | Reduce 6.41% | 103,000 | $123.98 |
| Q2 2019 | +7,210 | Add 7.00% | 110,210 | $114.31 |
| Q3 2019 | -27,398 | Reduce 24.86% | 82,812 | $133.28 |
| Q4 2019 | -1,442 | Reduce 1.74% | 81,370 | $145.32 |
| Q1 2020 | +5,459 | Add 6.71% | 86,829 | $98.14 |
| Q2 2020 | -4,429 | Reduce 5.10% | 82,400 | $115.89 |
| Q3 2020 | -7,056 | Reduce 8.56% | 75,344 | $132.18 |
| Q4 2020 | -2,214 | Reduce 2.94% | 73,130 | $149.60 |
| Q2 2021 | -4,120 | Reduce 5.63% | 69,010 | $156.14 |
| Q3 2021 | +33,990 | Add 49.25% | 103,000 | $142.10 |
| Q4 2021 | +31,518 | Add 30.60% | 134,518 | $123.34 |
| Q1 2022 | -34,518 | Reduce 25.66% | 100,000 | $127.90 |
| Q2 2022 | +85,000 | Add 85.00% | 185,000 | $117.41 |
| Q3 2022 | -96,500 | Reduce 52.16% | 88,500 | $104.55 |
| Q4 2022 | -31,500 | Reduce 35.59% | 57,000 | $127.51 |
| Q1 2023 | -2,000 | Reduce 3.51% | 55,000 | $129.20 |
| Q2 2023 | -8,000 | Reduce 14.55% | 47,000 | $145.60 |
| Q3 2023 | +10,000 | Add 21.28% | 57,000 | $112.23 |
| Q4 2023 | +9,635 | Add 16.90% | 66,635 | $121.69 |
| Q1 2024 | -1,635 | Reduce 2.45% | 65,000 | $131.98 |
| Q2 2024 | +12,400 | Add 19.08% | 77,400 | $108.53 |
| Q3 2024 | +2,600 | Add 3.36% | 80,000 | $107.95 |
| Q2 2025 | -2,000 | Reduce 2.50% | 78,000 | $91.21 |
| Q4 2025 | +4,000 | Add 5.13% | 82,000 | $89.91 |
Robert Olstein's Zimmer Biomet Holdings Investment FAQs
Robert Olstein first purchased Zimmer Biomet Holdings, Inc. (ZBH) in Q2 2013, acquiring 93,730 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Zimmer Biomet Holdings, Inc. (ZBH) for 51 quarters since Q2 2013.
Robert Olstein's largest addition to Zimmer Biomet Holdings, Inc. (ZBH) was in Q4 2016, adding 176,980 shares worth $17.73 M.
According to the latest 13F filing for Q4 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 82,000 shares of Zimmer Biomet Holdings, Inc. (ZBH), valued at approximately $7.37 M.
As of the Q4 2025 filing, Zimmer Biomet Holdings, Inc. (ZBH) represents approximately 1.51% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in Zimmer Biomet Holdings, Inc. (ZBH) was 185,000 shares, as reported at the end of Q2 2022.